Opportunity
Review and identify effectiveness and cost-efficiency opportunities in worldwide Regulatory, R&D and Human Resources functions in a major Pharmaceutical company.
Results
Team recommendations identified collective savings of $20MM while maintaining or strengthening functional performance.